You guys can sit here and cheer lead all you want but it's up to Kim and Inovio to put up or shut up. A preclinical deal with Roche certainly is not going to cut it. Heck we did that ten years ago with Merck and it went nowhere.
I'm sure great HPV results or a partner for a late stage vaccine will shut this guy's mouth up. Up to Kim to come through until then Inovio will be a punching bag because of it's past failures and lack of progress. BTW 5 years into the Kim regime at Inovio one Phase 2 trail. Slow dredging in my book especially considering VGX had what appeared to be a full shelf of candidates premerger.
Wait, are you really trying to bash Dr. Kim for "one P2 trial in 5 years"?? You're a nobody man #$%$ are you thinking trying to talk big? Let's see your list of accomplishments... No #$%$ Dr. Kim will need to validate himself and his company with VGX-3100 data but it's coming so hold your horses. If the data is good this company is going to take off like nothing you've ever seen little guy. If it's bad then all human kind should be sad that day.